Osteogenesis imperfecta: diagnosis and treatment. 2017

Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
aBone and Mineral Unit, Division of Endocrinology, Universidade Federal de São Paulo, Brazil bAcademic Unit of Bone Metabolism, University of Sheffield, Sheffield, United Kingdom.

OBJECTIVE Here we summarize the diagnosis of osteogenesis imperfecta, discuss newly discovered genes involved in osteogenesis imperfecta, and review the management of this disease in children and adults. RESULTS Mutations in the two genes coding for collagen type I, COL1A1 and COL1A2, are the most common cause of osteogenesis imperfecta. In the past 10 years, defects in at least 17 other genes have been identified as responsible for osteogenesis imperfecta phenotypes, with either dominant or recessive transmission. Intravenous bisphosphonate infusions are the most widely used medical treatment. This has a marked effect on vertebra in growing children and can lead to vertebral reshaping after compression fractures. However, bisphosphonates are less effective for preventing long-bone fractures. At the moment, new therapies are under investigation. CONCLUSIONS Despite advances in the diagnosis and treatment of osteogenesis imperfecta, more research is needed. Bisphosphonate treatment decreases long-bone fracture rates, but such fractures are still frequent. New antiresorptive and anabolic agents are being investigated but efficacy and safety of these drugs, especially in children, need to be better established before they can be used in clinical practice.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010013 Osteogenesis Imperfecta COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I. Fragilitas Ossium,Lobstein Disease,Brittle Bone Disease,Lobstein's Disease,Osteogenesis Imperfecta Tarda,Osteogenesis Imperfecta with Blue Sclerae,Osteogenesis Imperfecta, Type 1,Osteogenesis Imperfecta, Type I,Disease, Lobstein,Disease, Lobstein's,Lobsteins Disease,Ossiums, Fragilitas,Osteogenesis Imperfecta Tardas
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002657 Child Development The continuous sequential physiological and psychological maturing of an individual from birth up to but not including ADOLESCENCE. Infant Development,Development, Child,Development, Infant
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090602 Collagen Type I, alpha 1 Chain A fibrillar collagen found predominantly in BONE and SKIN. COL1A1 Protein,Collagen Type I, alpha 1 Subunit,Collagen alpha 1 (I),Pro alpha 1 Collagen,Pro-alpha1(I) Collagen,Procollagen alpha1(I),Type I Collagen alpha 1,Protein, COL1A1
D050723 Fractures, Bone Breaks in bones. Bone Fractures,Broken Bones,Spiral Fractures,Torsion Fractures,Bone Fracture,Bone, Broken,Bones, Broken,Broken Bone,Fracture, Bone,Fracture, Spiral,Fracture, Torsion,Fractures, Spiral,Fractures, Torsion,Spiral Fracture,Torsion Fracture
D024042 Collagen Type I The most common form of fibrillar collagen. It is a major constituent of bone (BONE AND BONES) and SKIN and consists of a heterotrimer of two alpha1(I) and one alpha2(I) chains. Type 1 Collagen,Type I Collagen,Collagen, Type 1,Collagen, Type I

Related Publications

Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
June 2008, The Journal of the American Academy of Orthopaedic Surgeons,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
September 2014, Current osteoporosis reports,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
August 1997, Acta paediatrica Japonica : Overseas edition,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
February 1948, The Journal of bone and joint surgery. British volume,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
January 2008, Der Orthopade,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
June 2004, Presse medicale (Paris, France : 1983),
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
December 1994, Revue francaise de gynecologie et d'obstetrique,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
January 1988, Annals of the New York Academy of Sciences,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
April 1995, Acta obstetricia et gynecologica Scandinavica,
Telma Palomo, and Tatiane Vilaça, and Marise Lazaretti-Castro
January 2016, The Pan African medical journal,
Copied contents to your clipboard!